Feb. 13, 2020

Terrax Minerals, Zhittya Genesis Medicine, Taiga Gold, Emgold

Terrax Minerals, Zhittya Genesis Medicine, Taiga Gold, Emgold
Apple Podcasts podcast player iconSpotify podcast player icon
Apple Podcasts podcast player iconSpotify podcast player icon
Ellis chats with David Suda, the President and CEO of TerraX Minerals (TSX-V:TXR/OTC:TRXXF) about their 2020 Winter Drilling program at the Yellowknife Gold Project in Canada’s NWT. We catch up with Dan Montano, the CEO of Zhittya Genesis Medicine about the company’s FGF-1 drug designed to regrow blood vessels remediating Alzheimers, Parkinson’s, Heart Disease, Stroke and more. Tim Termuende with Taiga Gold Corp (CSE:TGC/OTC:TGGDF) discusses his company’s Fisher Property gold project in Saskatchewan. Ellis also speaks with David Watkinson, the President and CEO of Emgold Mining Corporation (TSX-V:EMR) (OTC:EGMCF)(FRA:EMLM) a gold, silver, and base metal exploration company focused on Nevada and Quebec. In this interview will we discuss the company’s recent news regarding EMGOLD and Rio Tinto’s (LSE:RIO) Kennecott Exploration signing an earn-in with option to Joint Venture Agreement for the New York Canyon Property in Nevada.